Top 5 Heal Care Stocks To Buy For 2019

Buying and holding growth stocks is a great way to predictably generate wealth over the long term. But not all growth stocks are created equal; the very best have unique characteristics that set them apart — and set up investors for years of success.

So we asked three top Motley Fool investors to each discuss a growth stock that successful investors can appreciate. Read on to learn why they like Markel (NYSE:MKL), Mastercard (NYSE:MA), and Apple (NASDAQ:AAPL).

IMAGE SOURCE: GETTY IMAGES.

Buy and hold this fantastic business

Steve Symington(Markel):In order to be a trulysuccessful investor, you need to have the patience to buy and hold shares of great companies for the long term. And it’s hard to think of a business that fills that mold better than Markel.

Top 5 Heal Care Stocks To Buy For 2019: Stryker Corporation(SYK)

Advisors’ Opinion:

  • [By Logan Wallace]

    US Bancorp DE grew its stake in Stryker Co. (NYSE:SYK) by 2.4% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 154,942 shares of the medical technology company’s stock after purchasing an additional 3,643 shares during the quarter. US Bancorp DE’s holdings in Stryker were worth $24,935,000 at the end of the most recent quarter.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close was Stryker Corp. (NYSE: SYK) which traded down about 5% at $170.33. The stocks 52-week range is $137.70 to $179.84. Volume was about 4 million compared to the daily average volume of 1.1 million.

  • [By Shane Hupp]

    Stryker Co. (NYSE:SYK) – Analysts at Oppenheimer decreased their Q4 2018 earnings estimates for Stryker in a research note issued to investors on Monday, July 16th. Oppenheimer analyst S. Lichtman now forecasts that the medical technology company will earn $2.13 per share for the quarter, down from their previous estimate of $2.14.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Stryker (SYK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Dan Caplinger]

    Finally, shares of Boston Scientific sank 6%. The medical device maker had jumped earlier in the week on reports that it might receive a takeover bid from industry peer Stryker (NYSE:SYK). Yet today, Stryker denied that it had been in acquisition talks with Boston Scientific, throwing cold water on the idea. With the downward push, Boston Scientific is now back to where the stock started the week before the reports surfaced in the first place. Boston Scientific will now apparently have to make the most of its own opportunities in the medical device space — at least unless another potential buyer comes around.

Top 5 Heal Care Stocks To Buy For 2019: New Residential Investment Corp.(NRZ)

Advisors’ Opinion:

  • [By Max Byerly]

    Stifel Financial Corp lifted its holdings in New Residential Investment Corp (NYSE:NRZ) by 7.7% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 259,274 shares of the real estate investment trust’s stock after acquiring an additional 18,473 shares during the quarter. Stifel Financial Corp’s holdings in New Residential Investment were worth $4,263,000 as of its most recent SEC filing.

  • [By Max Byerly]

    Here are some of the media stories that may have impacted Accern’s analysis:

    Get New Residential Investment alerts:

    On your bad day this might appear as a lifeline: New Residential Investment Corp. (NRZ) (fintelegraph.com) EPS Evaluation New Residential Investment Corp (NYSE: NRZ) (stocksmarketcap.com) Active Stock Evaluation New Residential Investment Corp. (NYSE: NRZ) (financerater.com) New Residential Investment Corp. (NRZ): Technical Indicators: (stockquote.review) What Do Analysts’ Recommend? New Residential Investment Corp. (NYSE:NRZ) (nasdaqjournal.com)

    Shares of New Residential Investment opened at $18.10 on Monday, Marketbeat.com reports. New Residential Investment has a 1-year low of $15.04 and a 1-year high of $18.43. The stock has a market cap of $6.08 billion, a price-to-earnings ratio of 6.40 and a beta of 0.90.

  • [By Stephan Byrd]

    Shares of New Residential Investment Corp (NYSE:NRZ) have been given an average recommendation of “Buy” by the ten analysts that are presently covering the stock, MarketBeat reports. Two equities research analysts have rated the stock with a hold rating, seven have given a buy rating and one has given a strong buy rating to the company. The average twelve-month price objective among analysts that have issued ratings on the stock in the last year is $18.87.

  • [By Ethan Ryder]

    Natixis Advisors L.P. reduced its position in shares of New Residential Investment Corp (NYSE:NRZ) by 23.2% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 235,486 shares of the real estate investment trust’s stock after selling 71,224 shares during the quarter. Natixis Advisors L.P. owned about 0.07% of New Residential Investment worth $3,874,000 as of its most recent filing with the Securities and Exchange Commission.

Top 5 Heal Care Stocks To Buy For 2019: KeyCorp(KEY)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on KeyCorp (KEY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Trexquant Investment LP purchased a new stake in KeyCorp (NYSE:KEY) during the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 196,090 shares of the financial services provider’s stock, valued at approximately $3,834,000.

  • [By ]

    That said, I never completely abandoned the space. I remain long Citigroup (C) , I am flat KeyCorp (KEY) , having managed to maximize that trade earlier this year. Recently, your pal even reloaded his Goldman Sachs (GS) long after having trimmed that position appropriately. That, friends, is based on my belief that volatility will allow this legendary firm to reclaim its reputation. This one, I’ll watch with great anticipation. They report on Tuesday, April 17. My trigger finger itches now.

  • [By Joseph Griffin]

    KEY (CURRENCY:KEY) traded up 0.6% against the U.S. dollar during the one day period ending at 13:00 PM Eastern on July 1st. During the last week, KEY has traded up 7.6% against the U.S. dollar. One KEY token can now be bought for about $0.0063 or 0.00000099 BTC on popular exchanges. KEY has a market cap of $0.00 and approximately $284,702.00 worth of KEY was traded on exchanges in the last day.

Top 5 Heal Care Stocks To Buy For 2019: Nuveen Massachusetts Premium Income Municipal Fund(NMT)

Advisors’ Opinion:

  • [By Joseph Griffin]

    News articles about Nuveen Massachusetts Pre Income Mun Fd (NYSE:NMT) have been trending somewhat positive this week, according to Accern Sentiment Analysis. The research group ranks the sentiment of media coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Nuveen Massachusetts Pre Income Mun Fd earned a daily sentiment score of 0.16 on Accern’s scale. Accern also assigned news stories about the financial services provider an impact score of 47.5987310031013 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

Top 5 Heal Care Stocks To Buy For 2019: UnitedHealth Group Incorporated(UNH)

Advisors’ Opinion:

  • [By ]

    On Tuesday, he’ll be tuning into UnitedHealth Group (UNH) , Goldman Sachs (GS) , Johnson & Johnson (JNJ) and IBM (IBM) . Cramer had great things to say about all four companies.

  • [By Sean Williams]

    Heading into 2018, Avalere estimated that 41% of all U.S. counties were expected to have just one insurer offering a health plan. This comes after UnitedHealth Group (NYSE:UNH), the nation’s largest insurer, pulled out of 31 of 34 states in 2017. After UnitedHealth Group lost $475 million from Obamacare in 2015 and predicted $650 million in ACA losses in 2016, it was no surprise to see the nation’s largest health insurer critical of the ACA.

  • [By Todd Campbell]

    In this episode of The Motley Fool’s Industry Focus: Healthcare, host Kristine Harjes and Motley Fool contributor Todd Campbell discuss how these companies are trying to reshape treatment, and what factors could determine which company captures more market share. Also, Harjes and Campbell explain why UnitedHealth Group (NYSE:UNH) investors ought to be paying more attention to the Medicare and Medicaid markets than to the market for employer-sponsored health insurance.

Leave a Reply

Your email address will not be published. Required fields are marked *